AI assistant
Sending…
C4 Therapeutics, Inc. — Director's Dealing 2021
Jun 22, 2021
33861_dirs_2021-06-21_a324907e-fd33-47e7-954d-97b2bd6bff21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2021-06-21
Reporting Person: White Lauren (Chief Financial Officer)
More from C4 Therapeutics, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 18